Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Riccardo De CarliDepartment of Pediatric Haematology and Oncology, Queen Fabiola Children Hospital, University Hospital of Brussels, 1020 Brussels, Belgium.
Viviana MinichiniDepartment of Neurosurgery, Erasme Hospital, University Hospital of Brussels, 1070 Brussels, Belgium.
Laetitia LebrunDepartment of Pathology, Erasme Hospital, University Hospital of Brussels, 1070 Brussels, Belgium.
An Van DammeDepartment of Pediatric Haematology and Oncology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, 1200 Brussels, Belgium.ORCID 0000-0002-7114-201X
Christophe ChantrainDivision of Pediatric Hematology-Oncology, Centre Hospitalier Chrétien (CHC), MontLégia, 4000 Liege, Belgium.
Anais FohnDepartment of Pediatric, Citadelle Hospital, 4000 Liege, Belgium.ORCID 0009-0004-1961-8721
Sandra JacobsPediatric Hematology and Oncology, Department of Pediatrics, University Hospitals Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-9455-5394
Frederik De SmetLaboratory for Precision Cancer Medicine, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, The Leuven Institute for Single Cell Omics (LISCO) and The Leuven Cancer Institute (LKI), KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-6669-3335
Pierre LeblondInstitut d'Hématologie et Oncologie Pédiatrique (iHOPE), Centre Leon Berard, 69008 Lyon, France.ORCID 0000-0002-7088-2614
Nicolas AndréService d'Hématologie et Oncologie Pédiatrique, University Hospital Timone, Assistance Publique-Hôpitaux de Marseille, 13385 Marseille, France.ORCID 0000-0002-6786-4968
Pierluigi CalòDepartment of Pediatric Haematology and Oncology, Queen Fabiola Children Hospital, University Hospital of Brussels, 1020 Brussels, Belgium.ORCID 0000-0002-6867-4031
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
From Diagnosis Delay to Targeted Therapy: A Retrospective Study of Pediatric DLGNT with a Comprehensive Literature Review. · full record | OpenQuestion